Tiotropium Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Device: Trelegy Ellipta;   Device: Stiolto Respimat;   Drug: Furoate/Umeclidinium/Vilanterol;   Drug: Tiotropium Bromide/Olodaterol Sponsor:   Boehringer Ingelheim Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2021 Category: Research Source Type: clinical trials